HomeARCH • CVE
Arch Biopartners Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 483.17K | 9.49% |
Net income | -624.35K | 45.64% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.03K | 52.88% |
Total assets | 549.65K | -69.28% |
Total liabilities | 4.32M | -47.50% |
Total equity | -3.77M | — |
Shares outstanding | 65.47M | — |
Price to book | -30.33 | — |
Return on assets | -234.19% | — |
Return on capital | 107.18% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -624.35K | 45.64% |
Cash from operations | -574.64K | -12.33% |
Cash from investing | — | — |
Cash from financing | 529.82K | 145.86% |
Net change in cash | -44.82K | 84.86% |
Free cash flow | 57.72K | 160.95% |
Previous close
$1.82
Day range
$1.78 - $1.86
Year range
$1.27 - $2.20
Market cap
122.59M CAD
Avg Volume
14.59K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
About
Founded
1983
Headquarters
Website
